Resverlogix Corp. (RVX.TO)

CAD 0.05

(12.5%)

Net Debt Summary of Resverlogix Corp.

  • Resverlogix Corp.'s latest annual net debt in 2022 was 6.45 Million USD , down -8.29% from previous year.
  • Resverlogix Corp.'s latest quarterly net debt in 2023 Q2 was 6.77 Million USD , up 225766766.67% from previous quarter.
  • Resverlogix Corp. reported annual net debt of 7.03 Million USD in 2021, up 8085157.47% from previous year.
  • Resverlogix Corp. reported annual net debt of -87.00 USD in 2020, down -100.0% from previous year.
  • Resverlogix Corp. reported quarterly net debt of 6.77 Million USD for 2023 Q2, up 225766766.67% from previous quarter.
  • Resverlogix Corp. reported quarterly net debt of 6.67 Million USD for 2023 Q3, down -1.42% from previous quarter.

Annual Net Debt Chart of Resverlogix Corp. (2022 - 2001)

Created with Highcharts 11.1.0YearsNet Debt20022004200620082010201220142016201820202022-20000000 CAD0 CAD20000000 CAD40000000 CAD60000000 CAD

Historical Annual Net Debt of Resverlogix Corp. (2022 - 2001)

Year Net Debt Net Debt Growth
2022 6.45 Million USD -8.29%
2021 7.03 Million USD 8085157.47%
2020 -87.00 USD -100.0%
2019 13.15 Million USD 85.66%
2018 7.08 Million USD 1106.81%
2017 587 Thousand USD -98.76%
2016 47.28 Million USD 141.15%
2015 19.6 Million USD -31.27%
2014 28.52 Million USD 10.23%
2013 25.87 Million USD 179.94%
2012 9.24 Million USD 222.24%
2011 -7.56 Million USD -57.45%
2010 -4.8 Million USD -5.69%
2009 -4.54 Million USD 20.16%
2008 -5.69 Million USD -158.23%
2007 9.77 Million USD -23.5%
2006 12.77 Million USD 566.67%
2005 -2.73 Million USD 58.85%
2004 -6.65 Million USD -4172.27%
2003 -155.72 Thousand USD 73.3%
2002 -583.13 Thousand USD -97.92%
2001 -294.62 Thousand USD 0.0%

Peer Net Debt Comparison of Resverlogix Corp.

Name Net Debt Net Debt Difference
Appili Therapeutics Inc. 8.09 Million CAD 20.263%
Eupraxia Pharmaceuticals Inc. -11.72 Million CAD 155.033%
Helix BioPharma Corp. -1.08 Million CAD 696.762%
Microbix Biosystems Inc. -4.96 Million CAD 230.03%
Medicenna Therapeutics Corp. -16.98 Million CAD 137.987%
Satellos Bioscience Inc. -22.06 Million CAD 129.234%
Oncolytics Biotech Inc. -31.11 Million CAD 120.735%
Sernova Corp. -8.58 Million CAD 175.136%